Discover
CRDF
Cardiff Oncology, Inc.
1.29
2 x 0.92
2 x 1.62
bid
ask
-
0.01
0.77%
2 @ 05:29 AM
1.26 -0.03 (1.98%)
| Ytd | -54.09% | |
| 1y | -63.25% |
1.26
day range
1.30
1.16
52 week range
4.56
| Open | 1.28 | Prev Close | 1.30 | Low | 1.26 | High | 1.30 | Mkt Cap | 88.20M |
| Vol | 564.19K | Avg Vol | 1.21M | EPS | -0.67 | P/E | N/A | Forward P/E | -4.03 |
| Beta | 1.93 | Short Ratio | 8.06 | Inst. Own | 27.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.57 | 200-d Avg | 1.99 | 1yr Est | 10.75 |
| Income Statement | |||
| Total Revenue | 41.00K | ||
| Revenues (USD) | 41.00K | ||
| Gross Profit | 41.00K | ||
| Operating Expenses | 12.89M | ||
| Research and Development Expense | 6.77M | ||
| Selling, General and Administrative Expense | 6.13M | ||
| Operating Income | -12.85M | ||
| Net Income | -12.34M | ||
| Net Income Common Stock | -12.35M | ||
| Net Income Common Stock (USD) | -12.35M | ||
| Consolidated Income | -12.34M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -12.34M | ||
| Earning Before Interest & Taxes (USD) | -12.34M | ||
| Preferred Dividends Income Statement Impact | 6.00K | ||
| Weighted Average Shares | 68.35M | ||
| Weighted Average Shares Diluted | 68.35M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.54M | ||
| Cash and Equivalents (USD) | 8.54M | ||
| Investments | 37.51M | ||
| Investments Current | 37.51M | ||
| Trade and Non-Trade Receivables | 191.00K | ||
| Current Assets | 47.34M | ||
| Property, Plant & Equipment Net | 986.00K | ||
| Total Assets | 49.17M | ||
| Debt Current | 646.00K | ||
| Total Debt | 646.00K | ||
| Current Liabilities | 14.46M | ||
| Total Liabilities | 14.46M | ||
| Accumulated Retained Earnings (Deficit) | -442.37M | ||
| Accumulated Other Comprehensive Income | -49.00K | ||
| Shareholders Equity | 34.71M | ||
| Shareholders Equity (USD) | 34.71M | ||
| Assets Non-Current | 1.83M | ||
| Total Debt (USD) | 646.00K | ||
| Trade and Non-Trade Payables | 5.48M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 221.00K | ||
| Net Cash Flow from Financing | 105.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.93M | ||
| Issuance (Purchase) of Equity Shares | 105.00K | ||
| Net Cash Flow from Investing | 3.26M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 3.26M | ||
| Net Cash Flow from Operations | -12.29M | ||
| Share Based Compensation | 1.66M | ||